

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | polyol transport (GO:0015791) | 8.90577698 |
| 2 | excretion (GO:0007588) | 7.63643945 |
| 3 | response to mercury ion (GO:0046689) | 7.60011117 |
| 4 | renal absorption (GO:0070293) | 7.19790690 |
| 5 | metanephric nephron tubule development (GO:0072234) | 6.46912634 |
| 6 | metanephric tubule development (GO:0072170) | 6.46912634 |
| 7 | adenine nucleotide transport (GO:0051503) | 6.27925714 |
| 8 | axon ensheathment in central nervous system (GO:0032291) | 6.13262110 |
| 9 | central nervous system myelination (GO:0022010) | 6.13262110 |
| 10 | lysine catabolic process (GO:0006554) | 6.11507291 |
| 11 | lysine metabolic process (GO:0006553) | 6.11507291 |
| 12 | metanephric nephron epithelium development (GO:0072243) | 6.01461514 |
| 13 | purine nucleotide transport (GO:0015865) | 5.77398829 |
| 14 | purine ribonucleotide transport (GO:0015868) | 5.66640323 |
| 15 | L-amino acid import (GO:0043092) | 5.55831695 |
| 16 | metanephric epithelium development (GO:0072207) | 5.51494205 |
| 17 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.50377194 |
| 18 | drug transmembrane transport (GO:0006855) | 5.48913094 |
| 19 | collecting duct development (GO:0072044) | 5.31387219 |
| 20 | cysteine metabolic process (GO:0006534) | 5.22312999 |
| 21 | urate metabolic process (GO:0046415) | 5.18800552 |
| 22 | phosphate ion transport (GO:0006817) | 5.16999979 |
| 23 | one-carbon compound transport (GO:0019755) | 5.16681906 |
| 24 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.03665665 |
| 25 | drug transport (GO:0015893) | 4.92473992 |
| 26 | branched-chain amino acid metabolic process (GO:0009081) | 4.90591838 |
| 27 | branched-chain amino acid catabolic process (GO:0009083) | 4.85924816 |
| 28 | homocysteine metabolic process (GO:0050667) | 4.85894873 |
| 29 | synaptic vesicle maturation (GO:0016188) | 4.84248330 |
| 30 | valine metabolic process (GO:0006573) | 4.83607612 |
| 31 | aspartate family amino acid catabolic process (GO:0009068) | 4.81901137 |
| 32 | glutamate secretion (GO:0014047) | 4.76837849 |
| 33 | amino acid import (GO:0043090) | 4.74669606 |
| 34 | phosphate ion transmembrane transport (GO:0035435) | 4.61894281 |
| 35 | organic cation transport (GO:0015695) | 4.60180047 |
| 36 | cellular modified amino acid catabolic process (GO:0042219) | 4.55610996 |
| 37 | nephron tubule development (GO:0072080) | 4.45753784 |
| 38 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.44697240 |
| 39 | synaptic vesicle exocytosis (GO:0016079) | 4.41558384 |
| 40 | actin filament depolymerization (GO:0030042) | 4.38805916 |
| 41 | potassium ion homeostasis (GO:0055075) | 4.28669596 |
| 42 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.23244373 |
| 43 | L-phenylalanine catabolic process (GO:0006559) | 4.23244373 |
| 44 | potassium ion import (GO:0010107) | 4.21526607 |
| 45 | 2-oxoglutarate metabolic process (GO:0006103) | 4.19302136 |
| 46 | glyoxylate metabolic process (GO:0046487) | 4.18860892 |
| 47 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.18224354 |
| 48 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.18060845 |
| 49 | short-chain fatty acid metabolic process (GO:0046459) | 4.12786638 |
| 50 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.12655934 |
| 51 | L-phenylalanine metabolic process (GO:0006558) | 4.12655934 |
| 52 | gamma-aminobutyric acid transport (GO:0015812) | 4.10676627 |
| 53 | postsynaptic membrane organization (GO:0001941) | 4.09026673 |
| 54 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.05512089 |
| 55 | response to parathyroid hormone (GO:0071107) | 4.04673703 |
| 56 | neurotransmitter uptake (GO:0001504) | 3.98981125 |
| 57 | cerebellar granule cell differentiation (GO:0021707) | 3.98852344 |
| 58 | quaternary ammonium group transport (GO:0015697) | 3.98724777 |
| 59 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.94975134 |
| 60 | aromatic amino acid family catabolic process (GO:0009074) | 3.92318906 |
| 61 | neuronal action potential propagation (GO:0019227) | 3.91369704 |
| 62 | renal tubule development (GO:0061326) | 3.89154099 |
| 63 | neuron cell-cell adhesion (GO:0007158) | 3.86980852 |
| 64 | toxin transport (GO:1901998) | 3.82510664 |
| 65 | sodium ion export (GO:0071436) | 3.81116433 |
| 66 | cellular sodium ion homeostasis (GO:0006883) | 3.80282203 |
| 67 | presynaptic membrane assembly (GO:0097105) | 3.79640750 |
| 68 | tryptophan catabolic process (GO:0006569) | 3.78372719 |
| 69 | indole-containing compound catabolic process (GO:0042436) | 3.78372719 |
| 70 | indolalkylamine catabolic process (GO:0046218) | 3.78372719 |
| 71 | regulation of synaptic vesicle transport (GO:1902803) | 3.77926518 |
| 72 | cell volume homeostasis (GO:0006884) | 3.76499112 |
| 73 | response to water (GO:0009415) | 3.76455639 |
| 74 | neurotransmitter secretion (GO:0007269) | 3.73125324 |
| 75 | locomotory exploration behavior (GO:0035641) | 3.71284854 |
| 76 | nephron epithelium development (GO:0072009) | 3.67120077 |
| 77 | tricarboxylic acid metabolic process (GO:0072350) | 3.65299383 |
| 78 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.63124672 |
| 79 | glutamate metabolic process (GO:0006536) | 3.62237633 |
| 80 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.57583116 |
| 81 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.56900471 |
| 82 | presynaptic membrane organization (GO:0097090) | 3.54429654 |
| 83 | cellular ketone body metabolic process (GO:0046950) | 3.53921271 |
| 84 | biotin metabolic process (GO:0006768) | 3.53859499 |
| 85 | kynurenine metabolic process (GO:0070189) | 3.51570053 |
| 86 | tryptophan metabolic process (GO:0006568) | 3.50338660 |
| 87 | cell communication by electrical coupling (GO:0010644) | 3.47553262 |
| 88 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.44827248 |
| 89 | water transport (GO:0006833) | 3.42771984 |
| 90 | cellular potassium ion homeostasis (GO:0030007) | 3.40750978 |
| 91 | amino-acid betaine transport (GO:0015838) | 3.38538548 |
| 92 | carnitine transport (GO:0015879) | 3.38538548 |
| 93 | protein localization to synapse (GO:0035418) | 3.36418926 |
| 94 | exploration behavior (GO:0035640) | 3.36055595 |
| 95 | amino-acid betaine metabolic process (GO:0006577) | 3.35598808 |
| 96 | vocalization behavior (GO:0071625) | 3.34510998 |
| 97 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.31501582 |
| 98 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.31393290 |
| 99 | nucleotide transport (GO:0006862) | 3.31369782 |
| 100 | cellular amino acid catabolic process (GO:0009063) | 3.28719941 |
| 101 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.28530000 |
| 102 | cardiovascular system development (GO:0072358) | 3.26335828 |
| 103 | proline metabolic process (GO:0006560) | 3.22562278 |
| 104 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.21902898 |
| 105 | cobalamin metabolic process (GO:0009235) | 3.21687533 |
| 106 | fatty acid beta-oxidation (GO:0006635) | 3.21068136 |
| 107 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.19537540 |
| 108 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.18972112 |
| 109 | synaptic transmission, glutamatergic (GO:0035249) | 3.18495956 |
| 110 | regulation of synapse structural plasticity (GO:0051823) | 3.18133112 |
| 111 | sulfur amino acid catabolic process (GO:0000098) | 3.17910696 |
| 112 | drug catabolic process (GO:0042737) | 3.15995119 |
| 113 | cGMP-mediated signaling (GO:0019934) | 3.15892698 |
| 114 | neurotransmitter transport (GO:0006836) | 3.15789839 |
| 115 | vitamin D metabolic process (GO:0042359) | 3.13842897 |
| 116 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.13263897 |
| 117 | neuronal ion channel clustering (GO:0045161) | 3.11854439 |
| 118 | alpha-amino acid catabolic process (GO:1901606) | 3.10428136 |
| 119 | fluid transport (GO:0042044) | 3.09477318 |
| 120 | acidic amino acid transport (GO:0015800) | 3.08062638 |
| 121 | negative regulation of digestive system process (GO:0060457) | 3.05725885 |
| 122 | exocrine pancreas development (GO:0031017) | 3.05590232 |
| 123 | serine family amino acid biosynthetic process (GO:0009070) | 3.05565637 |
| 124 | innervation (GO:0060384) | 3.02001568 |
| 125 | nephron epithelium morphogenesis (GO:0072088) | 3.01950775 |
| 126 | nephron tubule morphogenesis (GO:0072078) | 3.01950775 |
| 127 | regulation of neurotransmitter secretion (GO:0046928) | 3.01660847 |
| 128 | transepithelial transport (GO:0070633) | 3.00784755 |
| 129 | digestion (GO:0007586) | 3.00747459 |
| 130 | C4-dicarboxylate transport (GO:0015740) | 3.00181371 |
| 131 | positive regulation of membrane potential (GO:0045838) | 2.99467205 |
| 132 | serine family amino acid metabolic process (GO:0009069) | 2.99160298 |
| 133 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.98562581 |
| 134 | ketone body metabolic process (GO:1902224) | 2.98295159 |
| 135 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.96802383 |
| 136 | regulation of neurotransmitter levels (GO:0001505) | 2.96147033 |
| 137 | fatty acid oxidation (GO:0019395) | 2.96082868 |
| 138 | intestinal cholesterol absorption (GO:0030299) | 2.95235763 |
| 139 | amine catabolic process (GO:0009310) | 2.95225450 |
| 140 | cellular biogenic amine catabolic process (GO:0042402) | 2.95225450 |
| 141 | lipid oxidation (GO:0034440) | 2.94858910 |
| 142 | regulation of neurotransmitter transport (GO:0051588) | 2.92725421 |
| 143 | renal system process (GO:0003014) | 2.92090736 |
| 144 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.92034243 |
| 145 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.91784414 |
| 146 | astrocyte development (GO:0014002) | 2.90371917 |
| 147 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.90122072 |
| 148 | carboxylic acid catabolic process (GO:0046395) | 2.90075533 |
| 149 | organic acid catabolic process (GO:0016054) | 2.90075533 |
| 150 | auditory behavior (GO:0031223) | 2.89945663 |
| 151 | serine family amino acid catabolic process (GO:0009071) | 2.89397675 |
| 152 | carnitine metabolic process (GO:0009437) | 2.88118610 |
| 153 | negative regulation of neurotransmitter transport (GO:0051589) | 2.87432391 |
| 154 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.87084910 |
| 155 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.86665723 |
| 156 | regulation of synaptic plasticity (GO:0048167) | 2.86485498 |
| 157 | exogenous drug catabolic process (GO:0042738) | 2.86161018 |
| 158 | neuromuscular process controlling balance (GO:0050885) | 2.86149098 |
| 159 | glutamate receptor signaling pathway (GO:0007215) | 2.85918686 |
| 160 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.85155653 |
| 161 | fatty acid catabolic process (GO:0009062) | 2.84940179 |
| 162 | detection of calcium ion (GO:0005513) | 2.84002100 |
| 163 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.82327460 |
| 164 | neuron-neuron synaptic transmission (GO:0007270) | 2.81375491 |
| 165 | sodium ion transport (GO:0006814) | 2.80458109 |
| 166 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.79927702 |
| 167 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.79440769 |
| 168 | regulation of ARF protein signal transduction (GO:0032012) | 2.78439367 |
| 169 | acetyl-CoA metabolic process (GO:0006084) | 2.78018566 |
| 170 | response to auditory stimulus (GO:0010996) | 2.76850288 |
| 171 | synaptic vesicle endocytosis (GO:0048488) | 2.76649390 |
| 172 | urinary tract smooth muscle contraction (GO:0014848) | 2.76296123 |
| 173 | L-glutamate transport (GO:0015813) | 2.75773902 |
| 174 | dicarboxylic acid catabolic process (GO:0043649) | 2.75615883 |
| 175 | glutathione biosynthetic process (GO:0006750) | 2.75520140 |
| 176 | regulation of postsynaptic membrane potential (GO:0060078) | 2.72903002 |
| 177 | membrane depolarization during action potential (GO:0086010) | 2.70589271 |
| 178 | cochlea development (GO:0090102) | 2.69785859 |
| 179 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.69663676 |
| 180 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.67893518 |
| 181 | regulation of sensory perception of pain (GO:0051930) | 2.66567575 |
| 182 | regulation of sensory perception (GO:0051931) | 2.66567575 |
| 183 | positive regulation of synapse maturation (GO:0090129) | 2.66401399 |
| 184 | positive regulation of dendritic spine development (GO:0060999) | 2.64292190 |
| 185 | myelination (GO:0042552) | 2.63997951 |
| 186 | cell communication involved in cardiac conduction (GO:0086065) | 2.61838960 |
| 187 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.60729797 |
| 188 | glomerular basement membrane development (GO:0032836) | 2.60705736 |
| 189 | long-term synaptic potentiation (GO:0060291) | 2.60309183 |
| 190 | import into cell (GO:0098657) | 2.60053705 |
| 191 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.57161423 |
| 192 | regulation of vesicle fusion (GO:0031338) | 2.56191932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.86886647 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.84695983 |
| 3 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.38781280 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.33999327 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.28369561 |
| 6 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.18304151 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.17581774 |
| 8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.16448749 |
| 9 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.15826479 |
| 10 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.15117969 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.08234428 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.04499870 |
| 13 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.02513355 |
| 14 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.95890387 |
| 15 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.83938770 |
| 16 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.79138753 |
| 17 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.76807629 |
| 18 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.72649814 |
| 19 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.72033236 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.66199191 |
| 21 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.65545377 |
| 22 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.65545377 |
| 23 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.64986949 |
| 24 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.64970819 |
| 25 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.62273744 |
| 26 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.58308316 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.55586271 |
| 28 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.54002650 |
| 29 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.52054309 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.52037752 |
| 31 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.51722603 |
| 32 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.51159464 |
| 33 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.50222920 |
| 34 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.49589305 |
| 35 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.49390959 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.47297025 |
| 37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.46100142 |
| 38 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.43207186 |
| 39 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.42471769 |
| 40 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.40652702 |
| 41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.40440238 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.39915382 |
| 43 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.39764896 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.39711779 |
| 45 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.39436002 |
| 46 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.38517814 |
| 47 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.38045476 |
| 48 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.36741645 |
| 49 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.35027441 |
| 50 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.34998404 |
| 51 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.34138927 |
| 52 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.33555064 |
| 53 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.33364283 |
| 54 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.32641193 |
| 55 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31947971 |
| 56 | P300_19829295_ChIP-Seq_ESCs_Human | 1.30928356 |
| 57 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.30578559 |
| 58 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.29447231 |
| 59 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.28899726 |
| 60 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28274363 |
| 61 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.27935773 |
| 62 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.26872705 |
| 63 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.25866977 |
| 64 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.23994458 |
| 65 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.23250415 |
| 66 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.21798737 |
| 67 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.20785649 |
| 68 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19542846 |
| 69 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.19352900 |
| 70 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.18630067 |
| 71 | RXR_22108803_ChIP-Seq_LS180_Human | 1.18253453 |
| 72 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17175540 |
| 73 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17002053 |
| 74 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16078153 |
| 75 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.15938334 |
| 76 | TP53_16413492_ChIP-PET_HCT116_Human | 1.15302372 |
| 77 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14598699 |
| 78 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.12289626 |
| 79 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12206480 |
| 80 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.12005676 |
| 81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.11926986 |
| 82 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.11240478 |
| 83 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.10506898 |
| 84 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.10455446 |
| 85 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.08405177 |
| 86 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.08232074 |
| 87 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.08215627 |
| 88 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.07537919 |
| 89 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07147478 |
| 90 | KDM2B_26808549_Chip-Seq_REH_Human | 1.05779826 |
| 91 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.05599538 |
| 92 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05025486 |
| 93 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.04071025 |
| 94 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.03418340 |
| 95 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.03394372 |
| 96 | AR_25329375_ChIP-Seq_VCAP_Human | 1.03157632 |
| 97 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.03090355 |
| 98 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.02688930 |
| 99 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02141343 |
| 100 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.01025469 |
| 101 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.99100914 |
| 102 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.97412639 |
| 103 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.97010737 |
| 104 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.96809944 |
| 105 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96532966 |
| 106 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.96529078 |
| 107 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96396865 |
| 108 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96121155 |
| 109 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.95864023 |
| 110 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.95713086 |
| 111 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.95699040 |
| 112 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94412212 |
| 113 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.94411015 |
| 114 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.93895171 |
| 115 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.93207205 |
| 116 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.92966227 |
| 117 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.92546019 |
| 118 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.90527219 |
| 119 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.90228915 |
| 120 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88795641 |
| 121 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.88545100 |
| 122 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.88252332 |
| 123 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.88222045 |
| 124 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.87523359 |
| 125 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86582269 |
| 126 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86582269 |
| 127 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.84941830 |
| 128 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.84258186 |
| 129 | VDR_22108803_ChIP-Seq_LS180_Human | 0.84147840 |
| 130 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.83999495 |
| 131 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.80999957 |
| 132 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.80818966 |
| 133 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.79433122 |
| 134 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78805135 |
| 135 | AR_19668381_ChIP-Seq_PC3_Human | 0.78381647 |
| 136 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.77956460 |
| 137 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.77504586 |
| 138 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.76560240 |
| 139 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.76320164 |
| 140 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.75386295 |
| 141 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.75233873 |
| 142 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.75208410 |
| 143 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.74941181 |
| 144 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.74678625 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 8.11740013 |
| 2 | MP0003195_calcinosis | 6.38712265 |
| 3 | MP0005360_urolithiasis | 4.98339536 |
| 4 | MP0001756_abnormal_urination | 4.27902958 |
| 5 | MP0003880_abnormal_central_pattern | 3.82070523 |
| 6 | MP0005332_abnormal_amino_acid | 3.76195118 |
| 7 | MP0004270_analgesia | 3.60367245 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 3.28460839 |
| 9 | MP0005365_abnormal_bile_salt | 3.28259763 |
| 10 | MP0009643_abnormal_urine_homeostasis | 3.26590850 |
| 11 | MP0005423_abnormal_somatic_nervous | 3.22386341 |
| 12 | MP0001765_abnormal_ion_homeostasis | 3.16360715 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 3.12342208 |
| 14 | MP0004885_abnormal_endolymph | 2.79529303 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.73220374 |
| 16 | MP0002063_abnormal_learning/memory/cond | 2.68146985 |
| 17 | MP0005085_abnormal_gallbladder_physiolo | 2.65346736 |
| 18 | MP0002272_abnormal_nervous_system | 2.58805666 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.56395055 |
| 20 | MP0003252_abnormal_bile_duct | 2.49226764 |
| 21 | MP0002136_abnormal_kidney_physiology | 2.42393999 |
| 22 | MP0005636_abnormal_mineral_homeostasis | 2.36814828 |
| 23 | MP0003879_abnormal_hair_cell | 2.27461682 |
| 24 | MP0002572_abnormal_emotion/affect_behav | 2.26111694 |
| 25 | MP0003329_amyloid_beta_deposits | 2.21054530 |
| 26 | MP0001501_abnormal_sleep_pattern | 2.08676400 |
| 27 | MP0009780_abnormal_chondrocyte_physiolo | 1.98308161 |
| 28 | MP0000538_abnormal_urinary_bladder | 1.97801677 |
| 29 | MP0002653_abnormal_ependyma_morphology | 1.95375505 |
| 30 | MP0001984_abnormal_olfaction | 1.94715667 |
| 31 | MP0008961_abnormal_basal_metabolism | 1.92867820 |
| 32 | MP0002168_other_aberrant_phenotype | 1.92321430 |
| 33 | MP0005083_abnormal_biliary_tract | 1.92125876 |
| 34 | MP0000920_abnormal_myelination | 1.87605979 |
| 35 | MP0008569_lethality_at_weaning | 1.85788684 |
| 36 | MP0008875_abnormal_xenobiotic_pharmacok | 1.83043865 |
| 37 | MP0000569_abnormal_digit_pigmentation | 1.78203915 |
| 38 | MP0005377_hearing/vestibular/ear_phenot | 1.74416724 |
| 39 | MP0003878_abnormal_ear_physiology | 1.74416724 |
| 40 | MP0001970_abnormal_pain_threshold | 1.74409724 |
| 41 | MP0005646_abnormal_pituitary_gland | 1.73211692 |
| 42 | MP0002234_abnormal_pharynx_morphology | 1.71863751 |
| 43 | MP0005220_abnormal_exocrine_pancreas | 1.71637369 |
| 44 | MP0000778_abnormal_nervous_system | 1.70423603 |
| 45 | MP0003868_abnormal_feces_composition | 1.59220480 |
| 46 | MP0002733_abnormal_thermal_nociception | 1.57275584 |
| 47 | MP0004484_altered_response_of | 1.53828658 |
| 48 | MP0003634_abnormal_glial_cell | 1.48140313 |
| 49 | MP0005084_abnormal_gallbladder_morpholo | 1.47517641 |
| 50 | MP0003632_abnormal_nervous_system | 1.38570715 |
| 51 | MP0002102_abnormal_ear_morphology | 1.35236977 |
| 52 | MP0000604_amyloidosis | 1.34692676 |
| 53 | MP0000955_abnormal_spinal_cord | 1.34615213 |
| 54 | MP0001270_distended_abdomen | 1.30494163 |
| 55 | MP0002882_abnormal_neuron_morphology | 1.24950899 |
| 56 | MP0002066_abnormal_motor_capabilities/c | 1.24692733 |
| 57 | MP0002557_abnormal_social/conspecific_i | 1.24495343 |
| 58 | MP0001440_abnormal_grooming_behavior | 1.22162282 |
| 59 | MP0000566_synostosis | 1.21755462 |
| 60 | MP0002928_abnormal_bile_duct | 1.19132429 |
| 61 | MP0005167_abnormal_blood-brain_barrier | 1.19008796 |
| 62 | MP0005171_absent_coat_pigmentation | 1.18352725 |
| 63 | MP0005551_abnormal_eye_electrophysiolog | 1.17727652 |
| 64 | MP0004924_abnormal_behavior | 1.15095779 |
| 65 | MP0005386_behavior/neurological_phenoty | 1.15095779 |
| 66 | MP0004811_abnormal_neuron_physiology | 1.14015116 |
| 67 | MP0003690_abnormal_glial_cell | 1.11615440 |
| 68 | MP0001905_abnormal_dopamine_level | 1.09255257 |
| 69 | MP0001958_emphysema | 1.07561659 |
| 70 | MP0005535_abnormal_body_temperature | 1.07416828 |
| 71 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.07299571 |
| 72 | MP0010234_abnormal_vibrissa_follicle | 1.04914756 |
| 73 | MP0005058_abnormal_lysosome_morphology | 1.02414879 |
| 74 | MP0002876_abnormal_thyroid_physiology | 1.02202291 |
| 75 | MP0002229_neurodegeneration | 1.00685690 |
| 76 | MP0002896_abnormal_bone_mineralization | 0.99577633 |
| 77 | MP0000534_abnormal_ureter_morphology | 0.99017564 |
| 78 | MP0000230_abnormal_systemic_arterial | 0.98669257 |
| 79 | MP0002118_abnormal_lipid_homeostasis | 0.95742850 |
| 80 | MP0002152_abnormal_brain_morphology | 0.94238888 |
| 81 | MP0005451_abnormal_body_composition | 0.93983848 |
| 82 | MP0002735_abnormal_chemical_nociception | 0.93420211 |
| 83 | MP0003183_abnormal_peptide_metabolism | 0.92836699 |
| 84 | MP0001764_abnormal_homeostasis | 0.92142538 |
| 85 | MP0002135_abnormal_kidney_morphology | 0.90574203 |
| 86 | MP0001963_abnormal_hearing_physiology | 0.89912152 |
| 87 | MP0010329_abnormal_lipoprotein_level | 0.87519293 |
| 88 | MP0005165_increased_susceptibility_to | 0.83373689 |
| 89 | MP0004742_abnormal_vestibular_system | 0.82466880 |
| 90 | MP0005319_abnormal_enzyme/_coenzyme | 0.82093315 |
| 91 | MP0002638_abnormal_pupillary_reflex | 0.81646699 |
| 92 | MP0002909_abnormal_adrenal_gland | 0.81076756 |
| 93 | MP0004859_abnormal_synaptic_plasticity | 0.80461736 |
| 94 | MP0003638_abnormal_response/metabolism_ | 0.79481519 |
| 95 | MP0003959_abnormal_lean_body | 0.79034296 |
| 96 | MP0008874_decreased_physiological_sensi | 0.77861989 |
| 97 | MP0004130_abnormal_muscle_cell | 0.77641016 |
| 98 | MP0003633_abnormal_nervous_system | 0.76948648 |
| 99 | MP0001664_abnormal_digestion | 0.75998874 |
| 100 | MP0002069_abnormal_eating/drinking_beha | 0.74756648 |
| 101 | MP0006276_abnormal_autonomic_nervous | 0.74629765 |
| 102 | MP0002089_abnormal_postnatal_growth/wei | 0.73849333 |
| 103 | MP0002184_abnormal_innervation | 0.73640083 |
| 104 | MP0001346_abnormal_lacrimal_gland | 0.72811947 |
| 105 | MP0004215_abnormal_myocardial_fiber | 0.72659051 |
| 106 | MP0005395_other_phenotype | 0.72531229 |
| 107 | MP0003045_fibrosis | 0.71999206 |
| 108 | MP0001968_abnormal_touch/_nociception | 0.71076573 |
| 109 | MP0001486_abnormal_startle_reflex | 0.70834768 |
| 110 | MP0004858_abnormal_nervous_system | 0.69356288 |
| 111 | MP0009764_decreased_sensitivity_to | 0.69046872 |
| 112 | MP0000383_abnormal_hair_follicle | 0.67022041 |
| 113 | MP0003075_altered_response_to | 0.66230254 |
| 114 | MP0002067_abnormal_sensory_capabilities | 0.66077886 |
| 115 | MP0003186_abnormal_redox_activity | 0.65427682 |
| 116 | MP0002822_catalepsy | 0.65335336 |
| 117 | MP0001727_abnormal_embryo_implantation | 0.65018321 |
| 118 | MP0002752_abnormal_somatic_nervous | 0.64111445 |
| 119 | MP0000631_abnormal_neuroendocrine_gland | 0.63818786 |
| 120 | MP0000678_abnormal_parathyroid_gland | 0.63309996 |
| 121 | MP0002736_abnormal_nociception_after | 0.62436832 |
| 122 | MP0004142_abnormal_muscle_tone | 0.61918909 |
| 123 | MP0005503_abnormal_tendon_morphology | 0.60940768 |
| 124 | MP0004036_abnormal_muscle_relaxation | 0.60816016 |
| 125 | MP0003646_muscle_fatigue | 0.60706821 |
| 126 | MP0003300_gastrointestinal_ulcer | 0.60488978 |
| 127 | MP0010386_abnormal_urinary_bladder | 0.60349205 |
| 128 | MP0006036_abnormal_mitochondrial_physio | 0.60014881 |
| 129 | MP0002734_abnormal_mechanical_nocicepti | 0.59343849 |
| 130 | MP0000026_abnormal_inner_ear | 0.58665304 |
| 131 | MP0003136_yellow_coat_color | 0.58233422 |
| 132 | MP0003631_nervous_system_phenotype | 0.57684480 |
| 133 | MP0001299_abnormal_eye_distance/ | 0.57475945 |
| 134 | MP0003283_abnormal_digestive_organ | 0.57302678 |
| 135 | MP0009745_abnormal_behavioral_response | 0.56458434 |
| 136 | MP0009642_abnormal_blood_homeostasis | 0.55410821 |
| 137 | MP0009384_cardiac_valve_regurgitation | 0.54395186 |
| 138 | MP0001177_atelectasis | 0.54098298 |
| 139 | MP0005623_abnormal_meninges_morphology | 0.53659496 |
| 140 | MP0003137_abnormal_impulse_conducting | 0.53188716 |
| 141 | MP0001485_abnormal_pinna_reflex | 0.52386972 |
| 142 | MP0009250_abnormal_appendicular_skeleto | 0.51945257 |
| 143 | MP0000579_abnormal_nail_morphology | 0.51891185 |
| 144 | MP0002064_seizures | 0.51307383 |
| 145 | MP0000762_abnormal_tongue_morphology | 0.50044521 |
| 146 | MP0003635_abnormal_synaptic_transmissio | 0.49659328 |
| 147 | MP0004233_abnormal_muscle_weight | 0.49609420 |
| 148 | MP0002078_abnormal_glucose_homeostasis | 0.49162092 |
| 149 | MP0001502_abnormal_circadian_rhythm | 0.49099800 |
| 150 | MP0003953_abnormal_hormone_level | 0.47862967 |
| 151 | MP0005595_abnormal_vascular_smooth | 0.47483272 |
| 152 | MP0005666_abnormal_adipose_tissue | 0.45902021 |
| 153 | MP0009046_muscle_twitch | 0.44510286 |
| 154 | MP0003806_abnormal_nucleotide_metabolis | 0.43980907 |
| 155 | MP0000343_altered_response_to | 0.43887086 |
| 156 | MP0000609_abnormal_liver_physiology | 0.43293927 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 8.66485995 |
| 2 | Abnormality of chloride homeostasis (HP:0011422) | 8.49092455 |
| 3 | Polyuria (HP:0000103) | 8.45055938 |
| 4 | Hyperactive renin-angiotensin system (HP:0000841) | 8.15847313 |
| 5 | Hypomagnesemia (HP:0002917) | 7.85035079 |
| 6 | Abnormal urine output (HP:0012590) | 7.83127076 |
| 7 | Renal salt wasting (HP:0000127) | 7.41727340 |
| 8 | Hyperaldosteronism (HP:0000859) | 7.33964276 |
| 9 | Abnormality of renal excretion (HP:0011036) | 7.09162916 |
| 10 | Tetany (HP:0001281) | 7.04721380 |
| 11 | Abnormality of magnesium homeostasis (HP:0004921) | 6.67921985 |
| 12 | Papilledema (HP:0001085) | 6.62343367 |
| 13 | Abnormal drinking behavior (HP:0030082) | 6.33457572 |
| 14 | Polydipsia (HP:0001959) | 6.33457572 |
| 15 | Alkalosis (HP:0001948) | 6.02247392 |
| 16 | Gout (HP:0001997) | 5.27564685 |
| 17 | Abnormality of renin-angiotensin system (HP:0000847) | 5.25542022 |
| 18 | Focal motor seizures (HP:0011153) | 5.20415685 |
| 19 | Hypokalemia (HP:0002900) | 4.74806654 |
| 20 | Action tremor (HP:0002345) | 4.61736805 |
| 21 | Myokymia (HP:0002411) | 4.52712495 |
| 22 | Focal seizures (HP:0007359) | 4.09889756 |
| 23 | Abnormality of sodium homeostasis (HP:0010931) | 4.08538318 |
| 24 | Hypercalciuria (HP:0002150) | 3.76295870 |
| 25 | Abnormality of potassium homeostasis (HP:0011042) | 3.75089866 |
| 26 | Diplopia (HP:0000651) | 3.74916159 |
| 27 | Abnormality of binocular vision (HP:0011514) | 3.74916159 |
| 28 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.74347454 |
| 29 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.67724407 |
| 30 | Metaphyseal dysplasia (HP:0100255) | 3.67635787 |
| 31 | Increased purine levels (HP:0004368) | 3.61946512 |
| 32 | Hyperuricemia (HP:0002149) | 3.61946512 |
| 33 | Atonic seizures (HP:0010819) | 3.59825021 |
| 34 | Adrenal overactivity (HP:0002717) | 3.51456664 |
| 35 | Febrile seizures (HP:0002373) | 3.48113888 |
| 36 | Hyponatremia (HP:0002902) | 3.39959595 |
| 37 | Progressive cerebellar ataxia (HP:0002073) | 3.35854202 |
| 38 | Hyperglycinuria (HP:0003108) | 3.22937138 |
| 39 | Hemiplegia (HP:0002301) | 3.15614635 |
| 40 | Neurofibrillary tangles (HP:0002185) | 3.15404995 |
| 41 | Generalized tonic-clonic seizures (HP:0002069) | 3.09142279 |
| 42 | Epileptic encephalopathy (HP:0200134) | 3.01446402 |
| 43 | Hemiparesis (HP:0001269) | 3.00714522 |
| 44 | Truncal ataxia (HP:0002078) | 2.95897107 |
| 45 | Ankle clonus (HP:0011448) | 2.94870035 |
| 46 | Cerebral inclusion bodies (HP:0100314) | 2.90916158 |
| 47 | Absence seizures (HP:0002121) | 2.87414040 |
| 48 | Abnormality of purine metabolism (HP:0004352) | 2.86902762 |
| 49 | Nephrocalcinosis (HP:0000121) | 2.82665394 |
| 50 | Ketoacidosis (HP:0001993) | 2.70825382 |
| 51 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.70362023 |
| 52 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.69179815 |
| 53 | Abnormality of glycine metabolism (HP:0010895) | 2.69179815 |
| 54 | Dehydration (HP:0001944) | 2.64157127 |
| 55 | Dialeptic seizures (HP:0011146) | 2.63374425 |
| 56 | Scanning speech (HP:0002168) | 2.63001179 |
| 57 | Proximal tubulopathy (HP:0000114) | 2.56356037 |
| 58 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.53832686 |
| 59 | Split foot (HP:0001839) | 2.50277374 |
| 60 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.49633943 |
| 61 | Dysdiadochokinesis (HP:0002075) | 2.48590123 |
| 62 | Supranuclear gaze palsy (HP:0000605) | 2.47808881 |
| 63 | Hypophosphatemic rickets (HP:0004912) | 2.40432616 |
| 64 | Tubulointerstitial fibrosis (HP:0005576) | 2.38208245 |
| 65 | Obstructive sleep apnea (HP:0002870) | 2.37269056 |
| 66 | Ketosis (HP:0001946) | 2.34846196 |
| 67 | Megalencephaly (HP:0001355) | 2.33329205 |
| 68 | Spastic gait (HP:0002064) | 2.32663583 |
| 69 | Overgrowth (HP:0001548) | 2.31136917 |
| 70 | Chondrocalcinosis (HP:0000934) | 2.24133203 |
| 71 | Renal tubular acidosis (HP:0001947) | 2.24066816 |
| 72 | Intention tremor (HP:0002080) | 2.23478504 |
| 73 | Postural instability (HP:0002172) | 2.18321213 |
| 74 | Abnormality of Sharpey fibers (HP:0100685) | 2.13069134 |
| 75 | Mild short stature (HP:0003502) | 2.12685204 |
| 76 | Decreased circulating renin level (HP:0003351) | 2.12154891 |
| 77 | Mutism (HP:0002300) | 2.07548660 |
| 78 | Neonatal onset (HP:0003623) | 2.06505576 |
| 79 | Vomiting (HP:0002013) | 2.04694554 |
| 80 | Delayed CNS myelination (HP:0002188) | 2.04690269 |
| 81 | Dysmetria (HP:0001310) | 2.04241895 |
| 82 | Choanal stenosis (HP:0000452) | 2.02810477 |
| 83 | Epileptiform EEG discharges (HP:0011182) | 2.01155656 |
| 84 | Metabolic alkalosis (HP:0200114) | 11.2614072 |
| 85 | Hypokalemic alkalosis (HP:0001949) | 10.2166364 |
| 86 | Hypotension (HP:0002615) | 1.99879096 |
| 87 | Dysmetric saccades (HP:0000641) | 1.99873420 |
| 88 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.99574921 |
| 89 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.96215093 |
| 90 | Aplasia of the phalanges of the hand (HP:0009802) | 1.96215093 |
| 91 | Aplasia involving bones of the extremities (HP:0009825) | 1.96215093 |
| 92 | Lower limb muscle weakness (HP:0007340) | 1.95594515 |
| 93 | Sudden death (HP:0001699) | 1.92788099 |
| 94 | Hyperglycinemia (HP:0002154) | 1.92665225 |
| 95 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.91993218 |
| 96 | Torticollis (HP:0000473) | 1.91970485 |
| 97 | Anxiety (HP:0000739) | 1.91760423 |
| 98 | Urinary urgency (HP:0000012) | 1.91741741 |
| 99 | Gaze-evoked nystagmus (HP:0000640) | 1.90304661 |
| 100 | Generalized aminoaciduria (HP:0002909) | 1.89831517 |
| 101 | Abnormality of nucleobase metabolism (HP:0010932) | 1.89219061 |
| 102 | Large eyes (HP:0001090) | 1.88960022 |
| 103 | Craniofacial hyperostosis (HP:0004493) | 1.88766120 |
| 104 | Increased density of long bones (HP:0006392) | 1.87820061 |
| 105 | Peripheral hypomyelination (HP:0007182) | 1.86401886 |
| 106 | Tubular atrophy (HP:0000092) | 1.84194554 |
| 107 | Pheochromocytoma (HP:0002666) | 1.83027146 |
| 108 | Enlarged epiphyses (HP:0010580) | 1.82920472 |
| 109 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.80668440 |
| 110 | Spinal canal stenosis (HP:0003416) | 1.78141288 |
| 111 | Generalized muscle weakness (HP:0003324) | 1.76888028 |
| 112 | Genetic anticipation (HP:0003743) | 1.76750953 |
| 113 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.76273059 |
| 114 | Dicarboxylic aciduria (HP:0003215) | 1.76273059 |
| 115 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.74827665 |
| 116 | Tetraplegia (HP:0002445) | 1.74338999 |
| 117 | Facial diplegia (HP:0001349) | 1.73469455 |
| 118 | Glomerulosclerosis (HP:0000096) | 1.72125099 |
| 119 | Abnormality of incisor morphology (HP:0011063) | 1.70833137 |
| 120 | Abnormality of urine glucose concentration (HP:0011016) | 1.70684399 |
| 121 | Glycosuria (HP:0003076) | 1.70684399 |
| 122 | Hyperammonemia (HP:0001987) | 1.70682266 |
| 123 | Cranial hyperostosis (HP:0004437) | 1.68880680 |
| 124 | Neoplasm of the heart (HP:0100544) | 1.66962776 |
| 125 | Postural tremor (HP:0002174) | 1.66374109 |
| 126 | Abnormality of the renal cortex (HP:0011035) | 1.65938731 |
| 127 | Hydroxyprolinuria (HP:0003080) | 1.65670244 |
| 128 | Abnormality of proline metabolism (HP:0010907) | 1.65670244 |
| 129 | EEG with generalized epileptiform discharges (HP:0011198) | 1.64405230 |
| 130 | Focal dystonia (HP:0004373) | 1.63641315 |
| 131 | Potter facies (HP:0002009) | 1.62769602 |
| 132 | Facial shape deformation (HP:0011334) | 1.62769602 |
| 133 | Impaired vibratory sensation (HP:0002495) | 1.61069277 |
| 134 | Poor eye contact (HP:0000817) | 1.60733997 |
| 135 | Abnormality of the diencephalon (HP:0010662) | 1.60352811 |
| 136 | Confusion (HP:0001289) | 1.59961592 |
| 137 | Metaphyseal cupping (HP:0003021) | 1.58243235 |
| 138 | Neuroendocrine neoplasm (HP:0100634) | 1.57859748 |
| 139 | Alacrima (HP:0000522) | 1.57822464 |
| 140 | Neuronal loss in central nervous system (HP:0002529) | 1.56591156 |
| 141 | Methylmalonic aciduria (HP:0012120) | 1.56252536 |
| 142 | Nephrolithiasis (HP:0000787) | 1.54573699 |
| 143 | Tubulointerstitial abnormality (HP:0001969) | 1.51720156 |
| 144 | Spastic paraparesis (HP:0002313) | 1.47966385 |
| 145 | Metabolic acidosis (HP:0001942) | 1.47807417 |
| 146 | Irritability (HP:0000737) | 1.47570127 |
| 147 | Impaired platelet aggregation (HP:0003540) | 1.46750702 |
| 148 | Abnormal platelet function (HP:0011869) | 1.46750702 |
| 149 | Vascular calcification (HP:0004934) | 1.42961915 |
| 150 | Abnormal tarsal ossification (HP:0008369) | 1.42466638 |
| 151 | Lethargy (HP:0001254) | 1.40386397 |
| 152 | Unilateral renal agenesis (HP:0000122) | 1.36122662 |
| 153 | Elfin facies (HP:0004428) | 1.35809660 |
| 154 | Renal tubular dysfunction (HP:0000124) | 1.30789977 |
| 155 | Hypophosphatemia (HP:0002148) | 1.29317072 |
| 156 | Abnormality of the renal medulla (HP:0100957) | 1.27925198 |
| 157 | Abnormal eating behavior (HP:0100738) | 1.27316901 |
| 158 | Cardiovascular calcification (HP:0011915) | 1.25483348 |
| 159 | Hyperphosphaturia (HP:0003109) | 1.25240588 |
| 160 | Sensorimotor neuropathy (HP:0007141) | 1.23146890 |
| 161 | Abnormal urine phosphate concentration (HP:0012599) | 1.19435961 |
| 162 | Enlarged kidneys (HP:0000105) | 1.18150187 |
| 163 | Hyperventilation (HP:0002883) | 1.17891790 |
| 164 | Abnormality of serum amino acid levels (HP:0003112) | 1.17364674 |
| 165 | Rickets (HP:0002748) | 1.16285656 |
| 166 | Status epilepticus (HP:0002133) | 1.14602035 |
| 167 | Abnormality of renal resorption (HP:0011038) | 1.13719232 |
| 168 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.13215183 |
| 169 | Tachypnea (HP:0002789) | 1.12366062 |
| 170 | Pancreatitis (HP:0001733) | 1.08275522 |
| 171 | Widely patent fontanelles and sutures (HP:0004492) | 1.05718931 |
| 172 | Intrahepatic cholestasis (HP:0001406) | 1.03774267 |
| 173 | Hyperkalemia (HP:0002153) | 1.03568757 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OXSR1 | 6.74850954 |
| 2 | WNK4 | 5.11776371 |
| 3 | BCKDK | 3.13618644 |
| 4 | CASK | 2.88339887 |
| 5 | SGK2 | 2.35211684 |
| 6 | SGK223 | 2.23586764 |
| 7 | SGK494 | 2.23586764 |
| 8 | WNK3 | 11.4496885 |
| 9 | SGK3 | 1.87854253 |
| 10 | UHMK1 | 1.72642158 |
| 11 | STK39 | 1.65760949 |
| 12 | NTRK1 | 1.64801599 |
| 13 | IRAK3 | 1.62839521 |
| 14 | MST4 | 1.57529118 |
| 15 | WNK1 | 1.53692371 |
| 16 | FRK | 1.34497832 |
| 17 | TYRO3 | 1.31863145 |
| 18 | LATS2 | 1.26299745 |
| 19 | MAPK13 | 1.25353263 |
| 20 | PKN1 | 1.18471160 |
| 21 | PLK2 | 1.17844893 |
| 22 | NTRK2 | 1.06740965 |
| 23 | PNCK | 1.06532468 |
| 24 | MST1R | 1.06212371 |
| 25 | AKT3 | 1.04633347 |
| 26 | CAMK2G | 1.03206406 |
| 27 | KSR2 | 0.97948453 |
| 28 | DMPK | 0.97049740 |
| 29 | PDK4 | 0.95418845 |
| 30 | PDK3 | 0.95418845 |
| 31 | PRPF4B | 0.94987717 |
| 32 | MAP3K9 | 0.94008564 |
| 33 | CAMK2A | 0.93618694 |
| 34 | SGK1 | 0.86756619 |
| 35 | FGFR2 | 0.86116588 |
| 36 | MUSK | 0.85611175 |
| 37 | TNK2 | 0.82835144 |
| 38 | TNIK | 0.81196958 |
| 39 | OBSCN | 0.79837684 |
| 40 | STK38 | 0.77872073 |
| 41 | MAP3K4 | 0.76513107 |
| 42 | MAPK10 | 0.76486603 |
| 43 | PDK2 | 0.73349069 |
| 44 | NEK6 | 0.72858930 |
| 45 | GRK5 | 0.71913132 |
| 46 | PINK1 | 0.71323969 |
| 47 | TIE1 | 0.71120903 |
| 48 | ARAF | 0.70937228 |
| 49 | ERN1 | 0.69545005 |
| 50 | MAP3K13 | 0.68410651 |
| 51 | PAK3 | 0.67712564 |
| 52 | MAP3K7 | 0.67008473 |
| 53 | NTRK3 | 0.66423406 |
| 54 | EPHA3 | 0.66169284 |
| 55 | STK38L | 0.65998170 |
| 56 | MARK2 | 0.63157833 |
| 57 | EPHA4 | 0.63132654 |
| 58 | RIPK4 | 0.62025143 |
| 59 | CAMK2D | 0.61601400 |
| 60 | ROCK1 | 0.60822786 |
| 61 | PRKD2 | 0.58543648 |
| 62 | ROCK2 | 0.58379530 |
| 63 | CDK15 | 0.57386657 |
| 64 | PDGFRA | 0.57370073 |
| 65 | TRIB3 | 0.55843436 |
| 66 | DYRK1A | 0.55601812 |
| 67 | CAMK1D | 0.55313625 |
| 68 | LATS1 | 0.54129484 |
| 69 | CDK18 | 0.52712770 |
| 70 | BMPR2 | 0.52095312 |
| 71 | DAPK1 | 0.51725073 |
| 72 | PDGFRB | 0.51706612 |
| 73 | MAP3K2 | 0.51415139 |
| 74 | CAMKK1 | 0.51256452 |
| 75 | IRAK2 | 0.51052553 |
| 76 | PRKCE | 0.50076265 |
| 77 | DAPK2 | 0.49570307 |
| 78 | CDK14 | 0.48849902 |
| 79 | PIK3CA | 0.48803512 |
| 80 | JAK1 | 0.48369576 |
| 81 | RET | 0.48117631 |
| 82 | CDK11A | 0.47790910 |
| 83 | PRKCH | 0.47781068 |
| 84 | PRKAA1 | 0.46986484 |
| 85 | CAMK1G | 0.46683836 |
| 86 | BMX | 0.46464291 |
| 87 | RIPK1 | 0.45803912 |
| 88 | MAPK7 | 0.43373637 |
| 89 | PAK6 | 0.42916051 |
| 90 | SIK1 | 0.41022149 |
| 91 | CAMK4 | 0.40864735 |
| 92 | PDPK1 | 0.40337435 |
| 93 | DDR2 | 0.39639150 |
| 94 | PRKG1 | 0.39454597 |
| 95 | LMTK2 | 0.39429479 |
| 96 | PTK2B | 0.39021688 |
| 97 | CCNB1 | 0.37327263 |
| 98 | MAPK12 | 0.36549081 |
| 99 | PRKAA2 | 0.35960099 |
| 100 | MINK1 | 0.35583380 |
| 101 | ERBB2 | 0.35191603 |
| 102 | MAPK4 | 0.34571951 |
| 103 | PHKG2 | 0.34275296 |
| 104 | PHKG1 | 0.34275296 |
| 105 | PRKCZ | 0.34257524 |
| 106 | FYN | 0.33726158 |
| 107 | BMPR1B | 0.33640740 |
| 108 | MAPKAPK5 | 0.33590847 |
| 109 | PRKD3 | 0.29227819 |
| 110 | IRAK1 | 0.29094806 |
| 111 | INSRR | 0.28058680 |
| 112 | MARK1 | 0.27893759 |
| 113 | PDK1 | 0.27633244 |
| 114 | TGFBR2 | 0.27363350 |
| 115 | PTK6 | 0.27048813 |
| 116 | MET | 0.26061460 |
| 117 | IKBKE | 0.26061073 |
| 118 | CSNK1A1 | 0.25270891 |
| 119 | NEK1 | 0.23702890 |
| 120 | MAPK11 | 0.23584315 |
| 121 | CDK5 | 0.22272492 |
| 122 | GRK1 | 0.22166877 |
| 123 | PRKACG | 0.22006396 |
| 124 | EIF2AK3 | 0.20420495 |
| 125 | IRAK4 | 0.20207098 |
| 126 | PRKACA | 0.20065691 |
| 127 | CAMKK2 | 0.19535643 |
| 128 | MAPK15 | 0.19525830 |
| 129 | LRRK2 | 0.18963420 |
| 130 | STK11 | 0.18726444 |
| 131 | GSK3A | 0.18026556 |
| 132 | RPS6KA3 | 0.17064698 |
| 133 | TBK1 | 0.16036593 |
| 134 | PRKCG | 0.15380281 |
| 135 | AKT2 | 0.14742775 |
| 136 | PRKCA | 0.13491759 |
| 137 | TAOK2 | 0.13447128 |
| 138 | PKN2 | 0.13318900 |
| 139 | FER | 0.12549948 |
| 140 | PRKCD | 0.11731411 |
| 141 | EPHB1 | 0.10874109 |
| 142 | CSNK1G2 | 0.10347797 |
| 143 | PTK2 | 0.10112807 |
| 144 | FGFR4 | 0.09452275 |
| 145 | MAP2K1 | 0.09339265 |
| 146 | PRKACB | 0.09200616 |
| 147 | CAMK1 | 0.09052681 |
| 148 | CAMK2B | 0.08691140 |
| 149 | MAP2K4 | 0.08080628 |
| 150 | ABL2 | 0.07975157 |
| 151 | CSNK1E | 0.07050162 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 4.21552703 |
| 2 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.29631751 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 3.16572357 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.15336071 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.06962925 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.87969420 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.65606086 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.62399666 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.45545997 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.43506343 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 2.24282065 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 2.23048899 |
| 13 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.21565899 |
| 14 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.18736770 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.15805101 |
| 16 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.10934916 |
| 17 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 2.10116784 |
| 18 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.07672474 |
| 19 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.01072363 |
| 20 | Morphine addiction_Homo sapiens_hsa05032 | 1.98245234 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.96268262 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.95643169 |
| 23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.94379804 |
| 24 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.92223683 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.87801111 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.78767523 |
| 27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.76093391 |
| 28 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.75710717 |
| 29 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.69760320 |
| 30 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.65329415 |
| 31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.57947577 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.53716867 |
| 33 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.52285908 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.44859247 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.43856687 |
| 36 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.43765468 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.41754530 |
| 38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.38573894 |
| 39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.36065057 |
| 40 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.33841130 |
| 41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.28787222 |
| 42 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.28653954 |
| 43 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.28057250 |
| 44 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.27786657 |
| 45 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.22640839 |
| 46 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.20216802 |
| 47 | Mineral absorption_Homo sapiens_hsa04978 | 1.18680907 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15854531 |
| 49 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.13419536 |
| 50 | Glioma_Homo sapiens_hsa05214 | 1.09729879 |
| 51 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.01684985 |
| 52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.00454876 |
| 53 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.00273605 |
| 54 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.00117184 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98388244 |
| 56 | Prion diseases_Homo sapiens_hsa05020 | 0.97788726 |
| 57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.96787198 |
| 58 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96620912 |
| 59 | Long-term depression_Homo sapiens_hsa04730 | 0.96373017 |
| 60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.95071106 |
| 61 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.93498080 |
| 62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.92360208 |
| 63 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.91767783 |
| 64 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.91313048 |
| 65 | Gap junction_Homo sapiens_hsa04540 | 0.90477734 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 0.89812331 |
| 67 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.89587565 |
| 68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.88341126 |
| 69 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.85770884 |
| 70 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.84550603 |
| 71 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.82037239 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.80611440 |
| 73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.80475417 |
| 74 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.79277022 |
| 75 | Melanogenesis_Homo sapiens_hsa04916 | 0.77685017 |
| 76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76340414 |
| 77 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.74899497 |
| 78 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.73687113 |
| 79 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73606505 |
| 80 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.70403927 |
| 81 | Olfactory transduction_Homo sapiens_hsa04740 | 0.68993280 |
| 82 | Lysine degradation_Homo sapiens_hsa00310 | 0.66300535 |
| 83 | Histidine metabolism_Homo sapiens_hsa00340 | 0.65573951 |
| 84 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63448079 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63435378 |
| 86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63189448 |
| 87 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.62800050 |
| 88 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.62331955 |
| 89 | Taste transduction_Homo sapiens_hsa04742 | 0.62147657 |
| 90 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62001070 |
| 91 | Salivary secretion_Homo sapiens_hsa04970 | 0.60054360 |
| 92 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58332068 |
| 93 | Insulin secretion_Homo sapiens_hsa04911 | 0.57790798 |
| 94 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.57757601 |
| 95 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.57697551 |
| 96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57666491 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57283051 |
| 98 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.56661838 |
| 99 | Axon guidance_Homo sapiens_hsa04360 | 0.56635100 |
| 100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.55743282 |
| 101 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55015007 |
| 102 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54772266 |
| 103 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54496662 |
| 104 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.54478485 |
| 105 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.54303874 |
| 106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49348869 |
| 107 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49280058 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48973553 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46536328 |
| 110 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.46446007 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.45809806 |
| 112 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.44485785 |
| 113 | Other glycan degradation_Homo sapiens_hsa00511 | 0.43830057 |
| 114 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.43406159 |
| 115 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42691284 |
| 116 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.41775492 |
| 117 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.38929783 |
| 118 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.38861073 |
| 119 | Focal adhesion_Homo sapiens_hsa04510 | 0.37929862 |
| 120 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.37534916 |
| 121 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35566559 |
| 122 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.35050321 |
| 123 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33679773 |
| 124 | Retinol metabolism_Homo sapiens_hsa00830 | 0.33506890 |
| 125 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.33202210 |
| 126 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32900456 |
| 127 | GABAergic synapse_Homo sapiens_hsa04727 | 0.30482482 |
| 128 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.28881414 |
| 129 | Insulin resistance_Homo sapiens_hsa04931 | 0.28381966 |
| 130 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.27600935 |
| 131 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.27377076 |
| 132 | Renin secretion_Homo sapiens_hsa04924 | 0.26704634 |
| 133 | Alzheimers disease_Homo sapiens_hsa05010 | 0.26452039 |
| 134 | Lysosome_Homo sapiens_hsa04142 | 0.25235106 |
| 135 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.24880550 |
| 136 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.22997952 |
| 137 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.19980252 |
| 138 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.15773880 |
| 139 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.13503009 |
| 140 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.12909655 |
| 141 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.11837823 |
| 142 | Endometrial cancer_Homo sapiens_hsa05213 | 0.11169198 |
| 143 | Hepatitis C_Homo sapiens_hsa05160 | 0.10838181 |
| 144 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.09713077 |
| 145 | Circadian rhythm_Homo sapiens_hsa04710 | 0.09489621 |
| 146 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.09294172 |
| 147 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.09284789 |
| 148 | Parkinsons disease_Homo sapiens_hsa05012 | 0.09188758 |

